$5.93 Billion Forecast for Vaccine Contract Manufacturing Market by 2029, Backed by Demand and Innovation
Discover trends, market shifts, and competitive outlooks for the vaccine contract manufacturing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has the Vaccine Contract Manufacturing Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for vaccine contract manufacturing has seen a significant surge recently. It is projected to swell from $3.58 billion in 2024 to $3.93 billion in 2025, marking a compound annual growth rate (CAGR) of 9.7%. This increase in the past years can be traced back to traditional limitations in vaccine manufacturing, heightened demand for vaccines due to global disease spreads, regulatory approval supporting contract manufacturing, the escalating intricacy in the production of vaccines, as well as a dramatic increase in vaccine research and development.
The market size for vaccine contract manufacturing is set to experience accelerated expansion in the upcoming years, with predictions pointing to a growth to $5.93 billion by the year 2029, marking a compound annual growth rate (CAGR) of 10.8%. The principal reasons stimulating growth throughout the forecast period include an intensifying focus on being prepared for pandemics, a surge in outsourcing within the pharmaceutical manufacturing sector, the growth of biopharmaceutical establishments, fast-tracked vaccine production timelines, and worldwide efforts to ensure vaccine availability. Key trends projected for the forecast interval incorporate the assimilation of single-use technologies in the manufacturing process, the emergence of personalized medicine for vaccine development, the growth of mRNA and viral vector vaccines, the adoption of continuous manufacturing procedures, and the broadening of fill-finish services.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp
What Are the Core Growth Drivers Propelling the Vaccine Contract Manufacturing Market Forward?
The expansion of the vaccine contract manufacturing market is anticipated to be fueled by rising initiatives promoting vaccinations. These vaccinations are a simple, effective, and safe mechanism to prevent infectious diseases from spreading, strengthening the immune system and increasing resilience against infections. The augmentation of these initiatives can stimulate enhancement and progression in various vaccine manufacturing procedures, thereby supporting vaccine contract manufacturing. As an illustration, in November 2022, the U.S. Department of Health and Human Services, a US government organ at the cabinet level, divulged a new initiative of $350 million for HRSA-supported health establishments to amplify the volume of COVID-19 vaccines in their respective communities, focusing particularly on underserved individuals. Consequently, the surge in initiatives promoting vaccinations is propelling the expansion of the vaccine contract manufacturing market.
What Segment Types Define the Vaccine Contract Manufacturing Market Structure?
The vaccine contract manufacturing market covered in this report is segmented –
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary
Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling
2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12216&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Vaccine Contract Manufacturing Market?
North America was the largest region in the vaccine contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing theVaccine Contract Manufacturing Industry Evolution?
Collaborative efforts are becoming an increasingly popular trend within the vaccine contract manufacturing sector. To maintain their standing in the market, major players are forming alliances with other companies within the same industry. For example, in January 2023, Vaxxas, an Australian biotech firm specializing in innovative needle-free vaccination methods, teamed up with the Norway-based Coalition for Epidemic Preparedness Innovations. This partnership was arranged to fund and supervise the creation of new vaccines and help advance Vaxxas’ needle-free vaccine patch delivery technology which could potentially eliminate the need for frozen storage of mRNA vaccines. Additionally, in October 2024, LenioBio, a German biotech company, joined forces with ReciBioPharm, a US-based contract development and manufacturing company, in order to boost their protein production capabilities and hasten the process of producing vaccines. This partnership is in line with LenioBio’s strategy to broaden the reach of its CEPI-financed project aimed at demonstrating the effectiveness and efficiency of its proprietary ALiCE protein expression technology for the generation of vaccine-related proteins suitable for clinical trials.
View the full report here:
What Is the Definition of the Vaccine Contract Manufacturing Market?
Vaccine contract manufacturing refers to an arrangement for creating vaccines with outside producers, who oversee producing, packing, and labeling vaccines according to the specifications and demands of the contracting business or organization. The primary benefit of vaccine contract manufacturing is that it simplifies production, resulting in cost savings and fewer difficulties.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12216
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
